Quince Therapeutics, Inc. (QNCX)
NASDAQ·Healthcare·Biotechnology
$1.23
-5.04%
Mkt Cap $5.85M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.20 | -$0.25 | -25.00% | — | — |
| Q3 2025 Aug 11, 2025 | — | — | — | -$0.28 | -$0.34 | -21.43% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.24 | -$0.34 | -41.67% | — | — |
| Q1 2025 Mar 24, 2025 | — | — | — | -$0.19 | -$0.28 | -47.37% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.17 | -$0.13 | +25.00% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | — | -$0.18 | — | — | — |
| Q2 2024 May 13, 2024 | — | — | — | — | -$0.26 | — | — | — |
| Q1 2024 Mar 11, 2024 | — | — | — | -$0.28 | -$0.22 | +21.43% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | — | -$0.15 | — | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.31 | -$0.34 | -9.95% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | -$0.29 | -$0.13 | +54.80% | — | — |
| Q4 2022 Nov 9, 2022 | — | — | — | -$0.28 | -$0.22 | +22.42% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.74 | -$0.51 | +31.08% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$0.55 | -$0.72 | -30.91% | — | — |
| Q1 2022 Mar 1, 2022 | — | — | — | -$0.65 | -$0.78 | -20.00% | — | — |
| Q4 2021 Nov 11, 2021 | — | — | — | -$0.74 | -$0.73 | +1.35% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.76 | -$0.74 | +2.63% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.72 | -$0.78 | -8.33% | — | — |
| Q1 2021 Mar 1, 2021 | — | — | — | -$0.73 | -$0.69 | +5.48% | — | — |